OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
Martina Arici, Mara Ferrandi, Paolo Barassi, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 231-244
Open Access | Times Cited: 17
Martina Arici, Mara Ferrandi, Paolo Barassi, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 231-244
Open Access | Times Cited: 17
Showing 17 citing articles:
Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump
Changwon Kho
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Changwon Kho
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Early consequences of the phospholamban mutation PLN‐R14del +/− in a transgenic mouse model
Claudia Maniezzi, Marem Eskandr, Chiara Florindi, et al.
Acta Physiologica (2024) Vol. 240, Iss. 3
Open Access | Times Cited: 7
Claudia Maniezzi, Marem Eskandr, Chiara Florindi, et al.
Acta Physiologica (2024) Vol. 240, Iss. 3
Open Access | Times Cited: 7
Intracellular Ca2+ signalling: unexpected new roles for the usual suspect
Francesco Moccia, Alessandra Fiorio, Dmitry Lim, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 14
Francesco Moccia, Alessandra Fiorio, Dmitry Lim, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 14
SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established
Adam Kia Shooshtarian, Kevin O’Gallagher, Ajay M. Shah, et al.
Heart Failure Reviews (2025)
Open Access
Adam Kia Shooshtarian, Kevin O’Gallagher, Ajay M. Shah, et al.
Heart Failure Reviews (2025)
Open Access
Ca 2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction
Fabrice Antigny, Rui Luo, Romain Perrier, et al.
Circulation Heart Failure (2025)
Closed Access
Fabrice Antigny, Rui Luo, Romain Perrier, et al.
Circulation Heart Failure (2025)
Closed Access
Selective SERCA2a activator as a candidate for chronic heart failure therapy
Martina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Martina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Beatrice Badone, Carlotta Ronchi, Francesco Lodola, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13500-13500
Open Access | Times Cited: 23
Beatrice Badone, Carlotta Ronchi, Francesco Lodola, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13500-13500
Open Access | Times Cited: 23
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
Andrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7324-7333
Open Access | Times Cited: 15
Andrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7324-7333
Open Access | Times Cited: 15
Fluorescence lifetime FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L. Yuen, Andrew R. Thompson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Osha Roopnarine, Samantha L. Yuen, Andrew R. Thompson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
Imma Forzano, Pasquale Mone, Gaetano Mottola, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7503-7503
Open Access | Times Cited: 10
Imma Forzano, Pasquale Mone, Gaetano Mottola, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7503-7503
Open Access | Times Cited: 10
Developmental Changes in the Excitation–Contraction Mechanisms of the Ventricular Myocardium and Their Sympathetic Regulation in Small Experimental Animals
Shogo Hamaguchi, Naoki Agata, Maika Seki, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 9, pp. 267-267
Open Access | Times Cited: 1
Shogo Hamaguchi, Naoki Agata, Maika Seki, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 9, pp. 267-267
Open Access | Times Cited: 1
Current Targets and Future Directions of Positive Inotropes for Heart Failure
Shadreen Fairuz, Ang Chee Wei, Fatima Mraiche, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 42, pp. 6971-6991
Closed Access | Times Cited: 3
Shadreen Fairuz, Ang Chee Wei, Fatima Mraiche, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 42, pp. 6971-6991
Closed Access | Times Cited: 3
Early consequences of the phospholamban mutation PLN-R14del+/-in a transgenic mouse model
Claudia Maniezzi, Marem Eskandr, Chiara Florindi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Claudia Maniezzi, Marem Eskandr, Chiara Florindi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Istaroxime: A Novel Therapeutic Agent for Acute Heart Failure
Danielle Newbury, William H. Frishman
Cardiology in Review (2023)
Closed Access | Times Cited: 1
Danielle Newbury, William H. Frishman
Cardiology in Review (2023)
Closed Access | Times Cited: 1
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L. Yuen, Andrew R. Thompson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Osha Roopnarine, Samantha L. Yuen, Andrew R. Thompson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators
Osha Roopnarine, Samantha L. Yuen, Andrew R. Thompson, et al.
Research Square (Research Square) (2023)
Open Access
Osha Roopnarine, Samantha L. Yuen, Andrew R. Thompson, et al.
Research Square (Research Square) (2023)
Open Access
Selective SERCA2a activator as a candidate for chronic heart failure therapy
Martina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Research Square (Research Square) (2023)
Open Access
Martina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Research Square (Research Square) (2023)
Open Access
